FRI607 SGLT2 Inhibition Improves Muscle Oxidative Capacity And Its Relationship With Cardiac Performance In Patients With T2D And Heart Failure

Disclosure: Y. Qin: None. N.D. Sanchez: None. A.J. Moody: None. F.M. Acosta: None. S. Neppala: None. M. Brown: None. H. Honka: None. B. Todd: None. L.A. Cruz Moreno: None. A.R. Stepanenko: None. S.E. Espinoza: None. N. Musi: None. C. Triplitt: None. G. Clarke: None. E. Cersosimo: None. R.A. DeFronzo...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yuejuan, Sanchez, Noah D, Moody, Alexander J, Acosta, Francisca M, Neppala, Sivaram, Brown, Marissa, Honka, Henri, Todd, Byron, Cruz Moreno, Luis A, Stepanenko, Allison R, Espinoza, Sara E, Musi, Nicolas, Triplitt, Curtis, Clarke, Geoffrey, Cersosimo, Eugenio, Anthony DeFronzo, Ralph, Solis-Herrera, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555090/
http://dx.doi.org/10.1210/jendso/bvad114.831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555090/
http://dx.doi.org/10.1210/jendso/bvad114.831

Ejemplares similares